Up next

Autoplay

Dr. Goldberg on Further Immunotherapy Trials in Non-Small Cell Lung Cancer

2 Views • 07/14/23
Share
Embed
administrator
administrator
Subscribers
0

Sarah Goldberg, MD, MPH, assistant professor of Medicine and Medical Oncology, Yale Cancer Center, discusses coming trials looking at immunotherapy beyond the second-line setting in non-small cell lung cancer (NSCLC). Goldberg says the most exciting part about these trial is finding out if combination immunotherapy treatment regimens could work better than single-agent regimens.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay